{
  "alleleExist":true,
  "dataVersion":"v4.5",
  "diagnosticImplications":[],
  "diagnosticSummary":"",
  "geneExist":true,
  "geneSummary":"EGFR, a receptor tyrosine kinase, is altered by amplification and/or mutation in lung and brain cancers among others.",
  "highestDiagnosticImplicationLevel":null,
  "highestFdaLevel":null,
  "highestPrognosticImplicationLevel":null,
  "highestResistanceLevel":null,
  "highestSensitiveLevel":null,
  "hotspot":false,
  "lastUpdate":"05/03/2023",
  "mutationEffect":{
    "citations":{
      "abstracts":[],
      "pmids":[]
    },
    "description":"",
    "knownEffect":"Unknown"
  },
  "oncogenic":"Unknown",
  "otherSignificantResistanceLevels":[],
  "otherSignificantSensitiveLevels":[],
  "prognosticImplications":[],
  "prognosticSummary":"",
  "query":{
    "alteration":"P373L",
    "alterationType":null,
    "consequence":"missense_variant",
    "entrezGeneId":1956,
    "hgvs":"7:g.55156644C>T",
    "hugoSymbol":"EGFR",
    "id":null,
    "proteinEnd":373,
    "proteinStart":373,
    "referenceGenome":"GRCh38",
    "svType":null,
    "tumorType":null
  },
  "treatments":[],
  "tumorTypeSummary":"",
  "variantExist":true,
  "variantSummary":"The EGFR P373L mutation has not been functionally or clinically validated.",
  "vus":true
}